Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Efficacy of GAX-65 demonstrated in pediatric study

Sep. 19, 1997

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

Sep. 18, 1997

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

Sep. 18, 1997

Gene Logic and Japan Tobacco enter genomic alliance

Sep. 15, 1997

NC-1800 now in phase II development

Sep. 15, 1997

PharmaPrint begins phase II trial of herbal treatment for BPH

Sep. 11, 1997

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Sep. 9, 1997

Agents useful for BPH from Pfizer

Sep. 9, 1997

Attenuation of cyclophosphamide-induced bladder damage in animals by GR-203040

Sep. 9, 1997

Uroselective alpha1-adrenoceptor antagonists for BPH

Sep. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld Science
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...